The aim of this study was to examine the echocardiographic features and associations of mitral valve prolapse (MVP) diagnosed by current two-dimensional echocardiographic criteria in an unselected outpatient sample.
Background
Previous studies of patients with MVP have emphasized the frequent occurrence of echocardiographic abnormalities such as significant mitral regurgitation (MR) and left atrial (LA) enlargement that are associated with clinical complications. These studies, however, have been limited by the use of hospital-based or referral series.
Methods
We quantitatively studied all 150 subjects with possible MVP by echocardiography and 150 age- and gender-matched subjects without MVP from the 3,491 subjects in the Framingham Heart Study. Based on leaflet morphology, subjects were classified as having classic (n = 46), nonclassic (n = 37), or no MVP.
Results
Leaflet length, MR degree, and LA and left ventricular size were significantly but mildly increased in MVP (p < 0.0001 to 0.004), with mean values typically within normal range. Average MR jet area was 15.1 ± 1.4% (mild) in classic MVP and 8.9 ± 1.5% (trace) in nonclassic MVP; MR was severe in only 3 of 46 (6.5%) subjects with classic MVP, and LA volume was increased in only 8.7% of those with classic MVP and 2.7% of those with nonclassic MVP.
Conclusions
Although the echocardiographic characteristics of subjects with MVP in the Framingham Heart Study differ from those without MVP, they display a far more benign profile of associated valvular, atrial, and ventricular abnormalities than previously reported in hospital- or referral-based series. Therefore, these findings may influence the perception of and approach to the outpatient with MVP.
Abbreviations
2-D
two-dimensional
LA
left atrial/atrium
LV
left ventricle/ventricular
LVIDd
left ventricular internal diameter in end-diastole
This work was supported by NIH/NHLBI contract N01-HC-38038, NIH/NINDS 5-R01-NS-17950-16, by NIH grants HL38176, HL53702, K24 HL67434, by the Doris Duke Charitable Foundation, and by the Roman W. DeSanctis Clinical Scholar Fund. We gratefully acknowledge the Hewlett-Packard Foundation Grant for upgrading our Hewlett Packard Ultrasound system to Sonos 1000 (Andover, Massachusetts).